This study compared the size, histology and morphology of coexisting neoplastic polyps found in colonoscopy, and evaluated the clustering of these polyps in patients with either colorectal carcinoma, cancerous polyps or benign adenomas. Patients were divided by their most malignant form of neoplasia: Group A included 58 patients with early invasive cancerous polyps, and Group B included 73 patients with in situ carcinoma within an adenoma. Group C consisted of 335 patients with benign adenomas, and Group D had 289 patients with colorectal carcinoma. There were no significant differences between the four groups regarding sex, age and ethnicity. The cancerous polyps were significantly larger than the benign polyps.
Introduction
Carcinomatous elements may be found in 5% of colorectal adenomas, 2 which are then termed cancerous or malignant polyps. They are divided into two subsets with different prognosis: (a) the carcinoma in situ, namely those confined to the mucosa, which practically do not have the ability to metastasize; (b) the invasive polyps, defined as adenomas, with a neoplastic process that extends beyond the muscularis mucosa or even beyond polyp boundaries. The question arises whether cancerous polyps represent an intermediate stage between benign adenomas and true cancers (benign -+ in situ -+ invasive -l cancer), or constitute a special group of polyps with different characteristics. It may be assumed that ifcancerous polyps were merely a link in the adenomacarcinoma sequence, then synchronous adenomas which appear in patients with either benign adenomas or cancerous polyps, or with carcinomas, would have similar characteristics. In this study we examined the synchronous adenomas of patients with different types of colorectal neoplasia.
Patients and methods
This retrospective study included four groups of patients, all of which were diagnosed by total colonoscopy during 1978-1988. Group A consisted of 58 patients with early invasive cancerous polyps, namely, polyps containing a focus of carcinoma which extends into or beyond the muscularis mucosa, but the polypectomy resection margin free of tumoral infiltration. Group B included 73 patients with adenomas containing a focus of severe dysplasia (carcinoma in situ Results (Table I) There were no differences between the four groups regarding age, sex and ethnicity of patients. Synchronous adenomas were found in 31 patients (54%) of Group A (invasive polyps) having 68 coexisting lesions and in 42 patients (58%) of Group B (carcinoma in situ) with 116 coexisting adenomas. The corresponding figures for Group C (benign adenomas) were 138 patients (41%) with 419 adenomas, and for Group D (cancer) -80 patients (28%) with 158 adenomas. Among patients with cancerous polyps there were significantly fewer patients with a single colonic lesion than in Groups C or D (P <0.006 and P < 10-6, respectively). Furthermore, in Groups A or B there were significantly more persons with > 5 polyps than in Groups C or D (P <0.01 for both). Coexisting polyps were much closer to the index growth in the case of cancerous polyps -if taken as a wholethan those associated with benign adenomas or cancer (P <0.02). However, a statistical significance was not reached in most distance analyses when Groups A or B were examined separately, probably because ofthe relatively small numbers of synchronous polyps included in these groups. Although cancerous polyps, the invasive ones in particular, were significantly larger than the adenomas of Group C (P <0.001), there were no size differences among the coexisting adenomas of Groups A, B or D as compared to Group C. Cancer patients had more synchronous villous adenomas than patients of all other groups, but the distribu- Ekelund and Lindstrom8 described a series of 960 patients with colorectal carcinoma of whom 22% had concomitant polyps. The investigators divided the colon into 6 segments and found that the benign neoplasms tended to cluster in the vicinity of the carcinomas. The phenomenon of clustering of synchronous neoplasms raises the question whether there is an influence of one tumour on the location of another tumour. Our data indicate that over 40% of the synchronous tumours were found within the same segment of the cancerous polyp, namely in a distance of less than 10 cm. Moreover, taking into consideration that the growth of a carcinoma might destroy adjacent polyps could mean that the above mentioned rate should be even higher. Recently, Cappell and Forde9 reported on 426 patients with multiple colon polyps. They found that both neoplastic and hyperplastic polyps tended to appear in clusters.
A major problem in the understanding of colorectal carcinogenesis is the fact that, in a colon which contains several adenomas, most remain small and benign while only one or two become highly dysplastic. There is still no clear explanation for this phenomenon, although luminal or humoral factors'0 and chromosomal alterations" have been proposed as pathogenetic mechanisms for tumour progression. We believe that cancerous polyps appear in patients whose colonic mucosa is more susceptible to neoplastic transformation compared to patients with benign polyps only or with carcinoma. The higher incidence of neoplasms around the cancerous polyps could mean either that these polyps induce local tumour promoting changes in their vicinity, or that cancerous polyps develop mainly in certain colonic areas characterized by mucosal predisposition for cancer development.
Hill et al.'" proposed a pathogenetic model based on three factors involved in carcinogenesis. Factor El produces small adenomas, factor E2 makes the small adenomas bigger and more dysplastic, and factor C induces carcinoma in a high proportion of adenomas. A change in the relative amounts of these factors may lead to different expressions concerning neoplastic alterations within the mucosa. One might speculate that patients with cancerous polyps are more likely to have increased activation of all three factors. In this situation we would expect multiple colon lesions, both benign and malignant, and more dysplastic changes including cancerous foci within adenomas. Our data seem to support this hypothesis. Furthermore, if this activity is more pronounced at certain locations, it could fit our observation that cancerous polyps were found to be close to other colon neoplasms. Another result which favours this hypothesis was the higher rate of severe dysplastic changes found in the coexisting benign polyps in Groups A and B. Similar findings were reported by Kalus'2 in cancer patients: 47% of synchronous polyps in the same segment showed severe dysplasia in contrast to an incidence of 6% for severe dysplastic changes found among patients with benign adenomas only.
Conclusions
In view of all these data we believe that cancerous polyps may not be just the middle link in the adenoma-carcinoma sequence, but rather constitute a marker for a special subset of patients who are more prone to the development of malignant transformation in their colonic mucosa. Hence, the finding of a cancerous polyp should allocate the patient into a higher risk group, and necessitate a more close and frequent colonoscopic surveillance.
